Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The medial branch of the dorsal ramus of each spinal nerve is a small peripheral nerve that supplies sensory innervation to the facet (zygapophyseal) joints of the spine, as well as the multifidus muscle and some posterior spinal ligaments. It plays a crucial role in transmitting pain signals from degenerated or inflamed facet joints to the central nervous system. These nerves are targeted in pain management procedures such as medial branch blocks, which involve injection of local anesthetic (and occasionally corticosteroid) to diagnose or treat facet-mediated back pain. Radiofrequency ablation of the medial branch nerve may provide longer-term relief by destroying its ability to transmit pain signals[1][2][3][4][5][6].
nerve blockade (inhibition of neuronal transmission of pain signals); ablation (nerve destruction with radiofrequency or other methods)[4][5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Medial branch of the dorsal ramus of spinal nerve.